Aprea Therapeutics, Inc. Common stock (NASDAQ: APRE) last traded at $0.593, down 1.87% on the session. The quote above updates while this page is open; the figures below are drawn from Aprea Therapeutics, Inc. Common stock’s own filings and are restated only when a new one is published.
Aprea Therapeutics, Inc. Common stock trades on NASDAQ under the ticker APRE. Its market capitalisation is $7.47 million.
Valuation measures for Aprea Therapeutics, Inc. Common stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $7.47M |
|---|---|
| Enterprise value | -$29.95M |
| Price / book | 0.19 |
| Beta | 0.81 |
Trailing-twelve-month figures tagged in Aprea Therapeutics, Inc. Common stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$12.31M |
| EPS (TTM) | -$1.03 |
|---|
| Return on equity | -31.99% |
|---|
| Cash | $41.23M |
|---|
Range and volume for APRE over the past 52 weeks.
| 52-week high | $1.69 |
|---|---|
| 52-week low | $0.548 |
| Volume | 106.4K |
| Average volume | 278.5K |
| Previous close | $0.604 |
Invest a chosen dollar amount in Aprea Therapeutics, Inc. Common stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell APRE.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.